Feb 28, 2022
|
Ardelyx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
|
Feb 24, 2022
|
Ardelyx Announces $27.5 Million Debt Financing Agreement with SLR Capital Partners
|
Feb 22, 2022
|
Ardelyx to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022
|
Feb 4, 2022
|
Ardelyx, Inc. Reports Employment Inducement Grants
|
Nov 30, 2021
|
Ardelyx Launching IBSRELA® Second Quarter of 2022
|
Nov 12, 2021
|
Ardelyx Reports Third Quarter 2021 Financial Results
|
Nov 11, 2021
|
Ardelyx to Present at the Jefferies London Healthcare Conference
|
Nov 5, 2021
|
Ardelyx Reports Additional Positive Data Supporting Clinical Utility of Tenapanor at ASN's Kidney Week 2021
|
Nov 4, 2021
|
Ardelyx to Pursue Formal Dispute Resolution for Tenapanor
|
Oct 29, 2021
|
Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021
|